GTC Biotherapeutics Collaborates With LFB Biotechnologies

BioPharm International Editors

GTC Biotherapeutics (Framingham, MA, http://www.gtc-bio.com) and LFB Biotechnologies (France) have signed an agreement to collaborate in the development of selected recombinant plasma proteins and monoclonal antibodies using GTC's transgenic production platform.

GTC Biotherapeutics (Framingham, MA, http://www.gtc-bio.com) and LFB Biotechnologies (France) have signed an agreement to collaborate in the development of selected recombinant plasma proteins and monoclonal antibodies using GTC’s transgenic production platform. A joint steering committee will agree on product development and commercialization plans.